---
figid: PMC9638655__JFMPC-11-4330-g001
figtitle: 'Blood-based biomarkers for diagnosis, prognosis, and severity prediction
  of COVID-19: Opportunities and challenges'
organisms:
- H5N1 subtype
- Japanese encephalitis virus
- Tick-borne encephalitis virus
- Coronaviridae
- Human coronavirus 229E
- Dengue virus
- Middle East respiratory syndrome-related coronavirus
- DNA viruses
- Severe acute respiratory syndrome coronavirus 2
- Human coronavirus NL63
- Human coronavirus HKU1
- Human coronavirus OC43
- Zika virus
- Severe acute respiratory syndrome-related coronavirus
- Homo sapiens
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC9638655
filename: JFMPC-11-4330-g001.jpg
figlink: /pmc/articles/PMC9638655/figure/jfmpc_2283_21-f001/
number: F1
caption: Highjacking the immune system and exaggerated inflammatory response by SARS-CoV-2
  infection of alveolar epithelial cells. (a) The SCoV-2 infected cells inhibit the
  antiviral response through TLR3/7 pathway. (b) The infected cell inhibits viral
  clearance by immune cells. (c) Excessive upregulation of cytokines causing cytokine
  storm and cell adhesion molecules. “This figure was prepared using Motifolio software
  for PowerPoint”
papertitle: 'Blood-based biomarkers for diagnosis, prognosis, and severity prediction
  of COVID-19: Opportunities and challenges.'
reftext: Rishabh Mittal, et al. J Family Med Prim Care. 2022 Aug;11(8):4330-4341.
year: '2022'
doi: 10.4103/jfmpc.jfmpc_2283_21
journal_title: Journal of Family Medicine and Primary Care
journal_nlm_ta: J Family Med Prim Care
publisher_name: Wolters Kluwer - Medknow
keywords: Aptamer | COVID-19 cellular biomarker and COVID-19 | cytokines | inflammation
  | multi-organ injury | SARS-CoV-2 biomarkers
automl_pathway: 0.9201711
figid_alias: PMC9638655__F1
figtype: Figure
redirect_from: /figures/PMC9638655__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9638655__JFMPC-11-4330-g001.html
  '@type': Dataset
  description: Highjacking the immune system and exaggerated inflammatory response
    by SARS-CoV-2 infection of alveolar epithelial cells. (a) The SCoV-2 infected
    cells inhibit the antiviral response through TLR3/7 pathway. (b) The infected
    cell inhibits viral clearance by immune cells. (c) Excessive upregulation of cytokines
    causing cytokine storm and cell adhesion molecules. “This figure was prepared
    using Motifolio software for PowerPoint”
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TLR3
  - SARS1
  - SARS2
  - TNF
  - IL6
  - IL1B
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - IFNA1
  - ACE2
  - GBP1P1
  - CD4
  - CD8A
  - CD8B
  - LINC00689
  - IL10
  - IL18
  - IL2
  - CSF2
  - LAMC2
  - TGFB1
  - TGFB2
  - TGFB3
  - CDH1
  - FZR1
  - ICAM1
  - VCAM1
  - SELE
  - SELL
  - SELP
  - MADCAM1
  - ITGA1
  - ITGA10
  - ITGA11
  - ITGA2
  - ITGA2B
  - ITGA3
  - ITGA4
  - ITGA5
  - ITGA6
  - ITGA7
  - ITGA8
  - ITGA9
  - ITGAD
  - ITGAE
  - ITGAL
  - ITGAM
  - ITGAV
  - ITGAX
  - ITGB1
  - ITGB2
  - ITGB3
  - ITGB4
  - ITGB5
  - ITGB6
  - ITGB7
  - ITGB8
  - ITGBL1
  - tlr3
  - sars1
  - tnfrsfa
  - tnfb
  - il6
  - ifnphi1
  - ace2
  - kita
  - ngfra
  - ighv1-1
  - cd4-1
  - il1b
  - il10
  - sele
  - cdh1
  - si:busm1-180o5.1
  - si:busm1-180o5.2
  - vcam1b
  - SARS
---
